Engineered T cells for cancer therapy

被引：95
|
作者：
June, Carl H. [1 ,2 ]
Maus, Marcela V. [1 ,3 ]
Plesa, Gabriela [1 ]
Johnson, Laura A. [1 ,2 ]
Zhao, Yangbing [1 ,2 ]
Levine, Bruce L. [1 ,2 ]
Grupp, Stephan A. [1 ,4 ]
Porter, David L. [1 ,3 ]
机构：
[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
来源：
CANCER IMMUNOLOGY IMMUNOTHERAPY | 2014年 / 63卷 / 09期
关键词：
Adoptive cell transfer; Gene transfer; Leukemia; Chimeric antigen receptor; 19th Danish Cancer Society Symposium; ADOPTIVE IMMUNOTHERAPY; ANTITUMOR-ACTIVITY; GENE-THERAPY; TOXICITY; REGRESSION; CD28; SPECIFICITY; PERSISTENCE; ACTIVATION; EXPRESSION;
D O I：
10.1007/s00262-014-1568-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
It is now well established that the immune system can control and eliminate cancer cells. Adoptive T cell transfer has the potential to overcome the significant limitations associated with vaccine-based strategies in patients who are often immune compromised. Application of the emerging discipline of synthetic biology to cancer, which combines elements of genetic engineering and molecular biology to create new biological structures with enhanced functionalities, is the subject of this focused research review.
引用
收藏
页码：969 / 975
页数：7
相关论文
共 50 条
  • [41] Targeting pancreatic cancer with TCR-engineered T cells
    Greenberg, Philip D.
    Anderson, Kristin G.
    Egan, Dan
    Hingorani, Sunil R.
    Nezi, Luigi
    Manzo, Teresa
    Oda, Shannon K.
    Paulson, Kelly G.
    Perret, Rachel
    Schmidt, Leah
    Schmitt, Tom M.
    Stromnes, Ingunn M.
    Chapuis, Aude G.
    CANCER RESEARCH, 2019, 79 (24)
  • [42] Engineered T Cells Improve Pancreatic Cancer Outcomes in Mice
    Fillon, Mike
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (08):
  • [43] Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment
    Sukumaran, Sujita
    Watanabe, Norihiro
    Bajgain, Pradip
    Raja, Kanchana
    Mohammed, Somala
    Fisher, William E.
    Brenner, Malcolm K.
    Leen, Ann M.
    Vera, Juan F.
    CANCER DISCOVERY, 2018, 8 (08) : 972 - 987
  • [44] Genetically engineered mesenchymal stromal cells in cancer gene therapy
    Matuskova, M.
    Durinikova, E.
    Altaner, C.
    Kucerova, L.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2018, 119 (04): : 221 - 223
  • [45] Engineering T cells for cancer therapy
    Mansoor, W
    Gilham, DE
    Thistlethwaite, FC
    Hawkins, RE
    BRITISH JOURNAL OF CANCER, 2005, 93 (10) : 1085 - 1091
  • [46] T Cells as the Future of Cancer Therapy
    Ribas, Antoni
    CANCER DISCOVERY, 2021, 11 (04) : 798 - 800
  • [47] Redirected T cells in cancer therapy
    Sangiolo, Dario
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1667 - 1670
  • [48] Engineering T cells for cancer therapy
    W Mansoor
    D E Gilham
    F C Thistlethwaite
    R E Hawkins
    British Journal of Cancer, 2005, 93 : 1085 - 1091
  • [49] Improving adoptive immune therapy using genetically engineered T cells
    Stroncek, David F.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [50] Engineered T-cell therapy shows efficacy in blood cancer
    Simon Frantz
    Nature Biotechnology, 2011, 29 : 853 - 854
12345